Employees State Insurance Corporation-ESIC has published E-Tender Enquiry Form For Rate Contract No 144C For Supply Of Drugs And Dressings. Submission Date for this Tender is 06-03-2021. Medicine Tenders in ESIC Head Quarters,New Delhi Delhi. Bidders can get complete Tender details and download the document.
Sr No | CorrigendumDate | Corrignedum | CorrigendumType | NewSubmissionDate |
1 | 04-Jan-2021 | Corrigendum | Other | 15-02-2021 |
2 | 15-Jan-2021 | Memorandum | Other | 15-02-2021 |
3 | 20-Jan-2021 | Memorandum Prebid Meeting | Other | 15-02-2021 |
4 | 11-Feb-2021 | Revised e-tender schdule with prebid corrigendum | Date | 06-03-2021 |
Name of Work: SUPPLY OF DRUGS & DRESSINGS | |||||
---|---|---|---|---|---|
Sl. No. | Item Description | Item Code / Make | Quantity | Units | |
1 | 1 | Chick Embryo Cell Rabies Vaccine- \nEach Dose to contain: 2.5 IU inactivated Rabies Antigen | Item no.: 282 | 1 | 1 Dose Pack |
2 | 2 | 5-Fluorouracil Inj- \nEach Vial to contain: Fluorouracil IP 250mg | Item no.: 286 | 1 | 1 Vial |
3 | 3 | Hydroxy Urea Tab/Cap- \nEach Tab/Cap to contain: Hydroxy Urea 500 mg | Item no.: 287 | 1 | 1 Tab/Cap |
4 | 4 | Cytosine Arabinoside Inj- \nEach Vial to contain: Cytosine Arabinoside 100mg | Item no.: 288 | 1 | 1 Vial |
5 | 5 | Tamoxifen Tab/Cap- \nEach Tab/Cap to contain: Tamoxifen 10mg | Item no.: 289 | 1 | 1 Tab/Cap |
6 | 6 | Etoposide Inj- \nEach Vial to contain: Etoposide IP 100mg | Item no.: 290 | 1 | 1 Vial |
7 | 7 | Bleomycin Inj- \nEach Vial to contain: Bleomycin IP 15IU | Item no.: 292 | 1 | 1 Vial |
8 | 8 | Vincristine Inj- \nEach Vial to contain: Vincristine IP 1mg | Item no.: 293 | 1 | 1 Vial |
9 | 9 | Doxorubicin Inj- \nEach 5 ml Vial to contain: Doxorubicin 10mg | Item no.: 402 | 1 | 1 Vial |
10 | 10 | Methotrexate Tab/Cap- \nEach Tab/Cap to contain: Methotrexate IP 2.5mg | Item no.: 403 | 1 | 1 Tab/Cap |
11 | 11 | Azathioprine Tab/Cap- \nEach Tab/Cap to contain: Azathioprine 50 mg | Item no.: 406 | 1 | 1 Tab/Cap |
12 | 12 | Ifosfamide Inj- \nEach Vial to contain: Ifosfamide 1gm | Item no.: 457 | 1 | 1 Vial |
13 | 13 | Fludarabine Inj- \nEach Vial to contain: Fludarabine 50mg | Item no.: 458 | 1 | 1 Vial |
14 | 14 | Flutamide Tab/Cap- \nEach Tab/Cap to contain: Flutamide 250mg | Item no.: 460 | 1 | 1 Tab/Cap |
15 | 15 | Mycophenolate Mofetil Tab/Cap- \nEach Tab/Cap to contain: Mycophenolate Mofetil 500mg | Item no.: 490 | 1 | 1 Tab/Cap |
16 | 16 | Imatinib Tab/Cap- \nEach Tab/Cap to contain: Imatinib Mesylate 100mg | Item no.: 504 | 1 | 1 Tab/Cap |
17 | 17 | Goserelin Inj- \nEach PFS to contain: Goserelin 3.6mg | Item no.: 526 | 1 | 1 PFS |
18 | 18 | Vero Cell Culture Rabies Vaccine- \nEach Dose to contain: Purified Vero Cell Culture Human Rabies Vaccine | Item no.: 542 | 1 | 1 DOSE PACK |
19 | 19 | Infliximab Inj- \nEach Vial to contain: Infliximab 100mg | Item no.: 600 | 1 | 1 Vial |
20 | 20 | Methotrexate Inj- \nEach Vial to contain: Methotrexate IP 50mg | Item no.: 1333 | 1 | 1 Vial |
21 | 21 | Tamoxifen Tab/Cap- \nEach Tab/Cap to contain:Tamoxifen 20mg | Item no.: 1334 | 1 | 1 Tab/Cap |
22 | 22 | Tetanus Vaccine (Adsorbed)- \nEach 0.5 ml to contain: Tetanus Toxoid 5/LFS | Item no.: 1341 | 1 | 1 Amp |
23 | 23 | Docetaxel Inj- \nEach Vial to contain: Docetaxel 80mg | Item no.: 1404 | 1 | 1 Vial |
24 | 24 | Temozolomide Tab/ Cap- \nEach Tab/Cap to contain: Temozolomide IP 250mg | Item no.: 1406 | 1 | 1 Tab/Cap |
25 | 25 | Nimotuzumab Inj- \nEach Vial to contain: Nimotuzumab 50mg | Item no.: 1448 | 1 | 10 ml Vial |
26 | 26 | CAPD Bag- \nEach bag to contain: CAPD Bag 7.5% Of Lcodextrin With Asymmetrical Y Connector | Item no.: 1456 | 1 | 2 Ltr Bag |
27 | 27 | Peg-Filgrastim Inj- \nEach PFS to contain: Peg-Filgrastim | Item no.: 1466 | 1 | 1 ml PFS |
28 | 28 | Human Albumin 20% Inj- \nEach Bott to contain: Human Albumin 20% | Item no.: 1471 | 1 | 50 ml bot |
29 | 29 | Anastrozole Tab/Cap- \nEach Tab/Cap to contain: Anastrozole 1mg | Item no.: 1475 | 1 | 1 Tab/Cap |
30 | 30 | Pemetrexed Disod. Inj- \nEach Vial to contain: Pemetrexed Disod. 500mg | Item no.: 1477 | 1 | 1 Vial |
31 | 31 | Lapatinib Tab/Cap- \nEach Tab/Cap to contain: Lapatinib 250mg | Item no.: 1640 | 1 | 1 Tab/Cap |
32 | 32 | Aprepitant Tab/Cap- \nEach Pack to contain: Aprepitant (125 mg One Tab/Cap and 80 mg Two Tab/Cap) | Item no.: 1641 | 1 | 1 Pack |
33 | 33 | Sevelamer Tab/Cap- \nEach Tab to contain: Sevelamer 400mg | Item no.: 1643 | 1 | 1 Tab/Cap |
34 | 34 | Paclitaxel Inj- \nEach Vial to contain: Inj Paclitaxel IP 30mg | Item no.: 1645 | 1 | 1 Vial |
35 | 35 | Bevacizumab Inj- \nEach Vial to contain: Inj Bevacizumab 100mg | Item no.: 1647 | 1 | 1 Vial |
36 | 36 | Trastuzumab Inj- \nEach Vial to contain: Inj Trastuzumab 440mg | Item no.: 1648 | 1 | 1 Vial |
37 | 37 | Polysaccharide Pneumococcal Vaccine- \nEach 0.5ml to contain: Polysaccharide Pneumococcal Vaccine 0.5ml | Item no.: 1651 | 1 | 1 PFS/ Vial |
38 | 38 | Tacrolimus Oint- \nEach Tube to contain: Tacrolimus 0.03% | Item no.: 1708 | 1 | 10gm Tube |
39 | 39 | Tacrolimus Oint- \nEach Tube to contain: Tacrolimus 0.1% | Item no.: 1709 | 1 | 10gm Tube |
40 | 40 | Gefitinib Tab/Cap- \nEach Tab/Cap to contain: Gefitinib 250mg | Item no.: 1728 | 1 | 1 Tab/Cap |
41 | 41 | Asparaginase Inj- \nEach Vial to contain: Asparaginase 10000 Unit | Item no.: 1729 | 1 | 1 Vial |
42 | 42 | Rasburicase Inj- \nEach Vial to contain: Rasburicase 1.5 mg | Item no.: 1731 | 1 | 1ml Vial |
43 | 43 | Decitabine Inj- \nEach Vial to contain: Decitabine 50mg | Item no.: 1732 | 1 | 1 Vial |
44 | 44 | Nilotinib Tab/Cap- \nEach Tab/Cap to contain: Nilotinib 150mg | Item no.: 1733 | 1 | 1 Tab/Cap |
45 | 45 | Imatinib Tab/Cap- \nEach Tab/Cap to contain: Imatinib Mesylate Equivalent to Imatinib 400 mg | Item no.: 1735 | 1 | 1 Tab/Cap |
46 | 46 | Bicalutamide Tab/Cap- \nEach Tab/Cap to contain: Bicalutamide 50mg | Item no.: 1736 | 1 | 1 Tab/Cap |
47 | 47 | Sevelamer Hcl Tab/Cap-\nEach Tab/Cap to contain: Sevelamer Hcl 800mg | Item no.: 1738 | 1 | 1 Tab/Cap |
48 | 48 | Methotrexate Tab/Cap- \nEach Tab/Cap to contain: Methotrexate 7.5mg | Item no.: 1802 | 1 | 1 Tab/Cap |
49 | 49 | Sorafenib Tab/Cap- \nEach Tab/Cap to contain: Sorafenib Tosylate 200mg | Item no.: 1803 | 1 | 1 Tab/Cap |
50 | 50 | Tacrolimus Tab/Cap- \nEach Tab/Cap to contain: Tacrolimus 1mg | Item no.: 1804 | 1 | 1 Tab/Cap |
51 | 51 | Tacrolimus Tab/Cap- \nEach Tab/Cap to contain: Tacrolimus 2mg | Item no.: 1805 | 1 | 1 Tab/Cap |
52 | 52 | Bortezomib Inj- \nEach Vial to contain: Bortezomib 1 mg | Item no.: 1808 | 1 | 1 Vial |
53 | 53 | Bortezomib Inj- \nEach Vial to contain: Bortezomib 3.5 mg | Item no.: 1809 | 1 | 1 Vial |
54 | 54 | Cetuximab Inj (100mg)- \nEach ml to contain: Cetuximab 5mg | Item no.: 1812 | 1 | 20ml Vial |
55 | 55 | Cetuximab Inj (500mg)- \nEach ml to contain: Cetuximab 5mg | Item no.: 1813 | 1 | 100ml Vial |
56 | 56 | Immunoglobulin- \nEach Inj to contain: Rho (D) Immune Globulin (Human) 1500 IU(300mcg) | Item no.: 1814 | 1 | 1 inj |
57 | 57 | Immunoglobulin- \nEach 1 ml Solution to contain: Active Substance(S) Human Plasma Proteins 50 mg, IgM 6 mg (12%) , IgA 6 mg (12%) IgG 38 mg (76%) | Item no.: 1819 | 1 | 10ml Vial |
58 | 58 | Anti Rabies Vaccine- \nEach ml to contain: HRG (Rabies Immunoglobulin (Human)) 150IU | Item no.: 1919 | 1 | 2ml Vial/Amp |
59 | 59 | Valganociclovir Tab/Cap- \nEach Tab/Cap to contain: Valganociclovir 450mg | Item no.: 1968 | 1 | 1 Tab/Cap |
60 | 60 | Mycophenolate Tab/Cap- \nEach Tab/Cap to contain: Mycophenolic Acid (As Sodium Salt) 180mg | Item no.: 1969 | 1 | 1 Tab/Cap |
61 | 61 | Mycophenolate Tab/Cap- \nEach Tab/Cap to contain: Mycophenolic Acid (As Sodium Salt) 360mg | Item no.: 1970 | 1 | 1 Tab/Cap |
62 | 62 | Mycophenolate Tab/Cap- \nEach Tab/Cap to contain: Mycophenolic Acid (As Sodium Salt) 540mg | Item no.: 1971 | 1 | 1 Tab/Cap |
63 | 63 | Leuprolide Inj- \nEach PFS/Vial to contain: Leuprolide Acetate Depot 3.75mg | Item no.: 1972 | 1 | 1 PFS/Vial |
64 | 64 | Leucovorin Inj- \nEach Vial to contain: Leucovorin 50mg | Item no.: 1979 | 1 | 1 Vial |
65 | 65 | Lenalidomide Tab/Cap- \nEach Tab/Cap to contain: Lenalidomide 5mg | Item no.: 1980 | 1 | 1 Tab/Cap |
66 | 66 | Oxaliplatin Inj- \nEach Vial to contain: Oxaliplatin 50mg | Item no.: 1982 | 1 | 1 Vial |
67 | 67 | Oxaliplatin Inj- \nEach Vial to contain: Oxaliplatin 100 Mg | Item no.: 1983 | 1 | 1 Vial |
68 | 68 | Paclitaxel Inj- \nEach Vial to contain: Paclitaxel 260mg | Item no.: 1984 | 1 | 1 Vial |
69 | 69 | Temozolomide Tab/Cap- \nEach Tab/Cap to contain: Temozolomide 100mg | Item no.: 1985 | 1 | 1 Tab/Cap |
70 | 70 | Zoledronic Acid Inj- \nEach Vial to contain: Zoledronic Acid 4mg | Item no.: 1986 | 1 | 1 Vial |
71 | 71 | Tacrolimus Tab/Cap- \nEach Tab/Cap to contain: Tacrolimus 0.5mg | Item no.: 1988 | 1 | 1 Tab/Cap |
72 | 72 | Sevelamer Sachet- \nEach Sachet to contain: Sevelamer Carbonate 800 mg | Item no.: 1990 | 1 | 1 Sachet |
73 | 73 | Alectinib Tab/Cap-\nEach Hard Gelatin Tab/Cap to contain: Alectinib 150 mg Equivalent To Alectinib Hydrocholoride 161.3 mg | Item no.: 2117 | 1 | 1 Tab/Cap |
74 | 74 | Atezolizumab Tab/Cap-\nEach 20ml Vial to contain: Atezolizumab Injection 1200mg | Item no.: 2118 | 1 | 1 Vial |
75 | 75 | Tofacitinib Tab/Cap- \nEach Film Coated Tab/Cap to contain : Tofacitinib Citrate Equivalent to Tofacitinib 5mg | Item no.: 2120 | 1 | 1 Tab/Cap |
76 | 76 | Adalimumab Inj-\nEach Pre-Filled Syringe to contain: Adalimumab 20mg/ 0.4ml Composition Adalimumab 20mg, Succinic Acid 0.472mg, Sodium Hydroxide NF Q.S. To pH 5.2 Sodium Chloride USP 2.336mg, L-Arginine Monohydrochloride USP 2mg, Sorbitol NF 4mg, Polysorbate 80 NF 0.04mg WFI Q.S. To 0.4ml | Item no.: 2121 | 1 | 1 PFS |
77 | 77 | Docetaxel Inj-\nEach Vial to contain: Docetaxel Lipid Suspension 80mg (Nanosomal) (Lyophilized) | Item no.: 2123 | 1 | 1 Vial |
78 | 78 | Pazopanib Tab/Cap-\nEach Film Coated Tab/Cap to contains Pazopanib Hydrochloride Equivalent to 400mg Pazopanib | Item no.: 2124 | 1 | 1 Tab/Cap |
79 | 79 | Eltrombopag Tab/Cap-\nEach Film Coated Tab/Cap to contain: Eltrombopag Olamine Equivalent to 25mg Of Eltrombopag as Eltrombopag Free Acid | Item no.: 2125 | 1 | 1 Tab/Cap |
80 | 80 | Eltrombopag Tab/Cap-\nEach Film Coated Tab/Cap to contain: Eltrombopag Olamine Equivalent to 50mg Of Eltrombopag as Eltrombopag Free Acid | Item no.: 2126 | 1 | 1 Tab/Cap |
81 | 81 | Ceritinib Tab/Cap-\nEach Hard Gelatin Tab/Cap to contain: Ceritinib 150mg | Item no.: 2127 | 1 | 1 Tab/Cap |
82 | 82 | Ibrutinib Tab/Cap-\nEach Cap/Tab to contain : Ibrutinib 140mg. | Item no.: 2128 | 1 | 1 Tab/Cap |
83 | 83 | Ruxolitinib Tab/Cap-\nEach Tab/Cap to contains Ruxolitinib 15mg | Item no.: 2129 | 1 | 1 Tab/Cap |
84 | 84 | Ruxolitinib Tab/Cap-\nEach Tab/Cap Contains Ruxolitinib 20mg | Item no.: 2130 | 1 | 1 Tab/Cap |
85 | 85 | Ruxolitinib Tab/Cap-\nEach Tab/Cap Contains Ruxolitinib 5mg | Item no.: 2131 | 1 | 1 Tab/Cap |
86 | 86 | Obinutuzumab Inj-\nEach Vial to contains: Obinutuzumab 1000 mg | Item no.: 2133 | 1 | 1 Vial |
87 | 87 | Nivolumab Inj-\nEach 4 ml Vial to contain: Nivolumab 40mg (40mg/4 ml) | Item no.: 2134 | 1 | 1 Vial |
88 | 88 | Nivolumab Inj-\nEach 10ml Vial to contains: Nivolumab 100mg (100mg/10ml) | Item no.: 2135 | 1 | 1 Vial |
89 | 89 | Pertuzumab Inj-\nEach 14ml Vial to contain: Pertuzumab 420mg (30mg/ml) | Item no.: 2136 | 1 | 1 Vial |
90 | 90 | Triptorelin Pamoate Inj-\nEach Single Dose Vial Contains:(Sterile Lypholized) Triptorelin Pamoate Equivalent to Triptorelin 11.25mg Pamorelin La 11.25 Inj. | Item no.: 2137 | 1 | 1 Vial |
91 | 91 | Crizotinib Tab/Cap- \nEach Hard Geletin Tab/Cap to contain : Crizotinib 250mg | Item no.: 2138 | 1 | 1 Tab/Cap |
92 | 92 | Denosumab Inj-\nEach Vial to contain: Denosumab 120 mg (70mg/ml) Total Fill 1.7ml In 5ml Vial | Item no.: 2139 | 1 | 1 Vial |
93 | 93 | Panitumumab Inj-\nEach Single Use Vial Of 5 ml to contain: Panitumumab 100 mg (20mg/ml) | Item no.: 2140 | 1 | 1 Vial |
94 | 94 | Carfilzomib Inj-\nEach Vial to contain: Carfilzomib 60mg Sterile Lypholized Powder | Item no.: 2141 | 1 | I Vial |
95 | 95 | Palbociclib Tab/Cap- \nEach Hard Gelatin Tab/Cap to contain: Palbociclib 125mg | Item no.: 2143 | 1 | 1 Tab/Cap |
96 | 96 | Afatinib Tab/Cap-\nEach Tab/Cap to contain: Afatinib 20 mg | Item no.: 2144 | 1 | 1 Tab/Cap |
97 | 97 | Afatinib Tab/Cap-\nEach Tab/Cap to contain: Afatinib 30 mg | Item no.: 2145 | 1 | 1 Tab/Cap |
98 | 98 | Paracetamol IV Inj- \nEach 50ml to contain Paracetamol IV 500mg | Item no.: 2146 | 1 | 50ml |
99 | 99 | Adalimumab Inj-\nEach Pre-Filled Syringe to contain: Adalimumab 40mg/ 0.8ml Composition Adalimumab 40mg, Succinic Acid 0.944mg, Sodium Hydroxide NF Q.S. to pH 5.2 Sodium Chloride USP 4.672mg, L-Arginine Monohydrochloride USP 4mg, Sorbitol NF 8mg, Polysorbate 80 NF 0.08mg, WFI Q.S. To 0.8ml | Item no.: 2147 | 1 | 1 PFS |
100 | 100 | Irinotecan Inj-\nEach 5ml Vial to contain: Irinotecan 100 mg | Item no.: 2148 | 1 | 1 Vial |
101 | 101 | Trastuzumab Inj-\nEach Vial to contain: Trastuzumab Emtansine 160mg | Item no.: 2149 | 1 | 1 Vial |
102 | 102 | Axitinib Tab/Cap-\nEach Film Coated Tab/Cap to contain: Axitinib 5 Mg | Item no.: 2153 | 1 | 1 Tab/Cap |
103 | 103 | Trabectedin Inj-\nEach Vial to contain:Trabectedin 1 Mg | Item no.: 2154 | 1 | 1 Vial |
104 | 104 | Permetrexed Inj-\nEach Vial to contain: Permetrexed 100mg | Item no.: 2155 | 1 | 1 Vial |
105 | 105 | Trastuzumab Inj-\nEach Vial to contain: Trastuzumab Emtansine 100mg | Item no.: 2156 | 1 | 1 Vial |
106 | 106 | Afatinib Tab/Cap-\nEach Tab/Cap to contain: Afatinib 40 mg | Item no.: 2157 | 1 | 1 Tab/Cap |
107 | 107 | Azacitidine Inj-\nEach Vial to contain: Azacitidine 100 mg | Item no.: 2159 | 1 | 1 Vial |
108 | 108 | Regorafenib Tab/Cap-\nEach Tab/Cap to contain: Regorafenib 40mg | Item no.: 2160 | 1 | 1 Tab/Cap |
109 | 109 | Fulvestrant Inj-\nEach Vial to contain: Fulvestrant 250mg | Item no.: 2161 | 1 | 1 Vial |
110 | 110 | Abiraterone Acetate Tab/Cap-\nEach Tab/Cap to contain: Abiraterone Acetate 250 Mg | Item no.: 2165 | 1 | 1 Tab/Cap |
111 | 111 | Docetaxel Inj-\nEach Vial to contain: Docetaxel Lipid Suspension 20mg (Nanosomal) (Lyophilized) | Item no.: 2166 | 1 | 1 Vial |
112 | 112 | Recombinant Human Granulocyte Inj-\nEach inj to contain: Recombinant Human Granulocyte Macrophage Colony Stimulating factor (r-hu-GMCSF) 500microgram | Item no.: 2167 | 1 | 1 Inj |
113 | 113 | Degarelix Inj-\nEach Vial to contain: Degarelix 80 mg | Item no.: 2169 | 1 | 1 Vial |
114 | 114 | Transtuzumab Inj-\nEach Vial to contain: Transtuzumab 150mg | Item no.: 2170 | 1 | 1 Vial |
115 | 115 | Erlotinib Tab/Cap-\nEach Tab/Cap to contain: Erlotinib 150 mg | Item no.: 2174 | 1 | 1 Tab/Cap |
116 | 116 | Bendamustine Inj-\nEach Vial to contain: Bendamustine Hcl 100mg | Item no.: 2175 | 1 | 1 Vial |
117 | 117 | Irinotecan Inj-\nEach 2ml Vial to contains: Irinotecan 40 mg | Item no.: 2176 | 1 | 1 Vial |
118 | 118 | Everolimus Tab/Cap-\nEach Tab/Cap to contains: Everolimus 5 mg | Item no.: 2178 | 1 | 1 Tab/Cap |
119 | 119 | Ramucirumab Concentrate For Solution For Infusion-\nEach Vial to contain: Ramucirumab 500mg / 50ml Vial Component :Ramucirumab 500mg,L-Histidine 32.5mg, L-Histidine Monohydrochloride 61.0mg, Glycine 499mg, Sodium Chloride 219mg, Polysorbate 80 5.0mg, Water For Injection Q.S | Item no.: 2179 | 1 | 50ml Vial |
120 | 120 | Secukinumab Inj-\nEach 1 ml to conatin: Secukinumab 150mg, Sucrose 92.43mg, L- Histidine / L- Histidine Hcl Monohydrate 4.656 mg, Polysorbate 80 - 0.60mg. | Item no.: 2180 | 1 | 1 Vial |
121 | 121 | Golimumab (r-DNA Origin)-\nEach Single Use Pre-Filled Syringe to contian: Golimumab 50mg/0.5ml Component [Amount Per Dose (Mg)]: Golimumab (CNTO 148) -50mg, Sorbitol -20.5mg, L-Histidine -0.44mg, Polysorbate 80 - 0.075mg, Water For Injection - 0.5mg | Item no.: 2181 | 1 | 1 PFS |
122 | 122 | Heparin Topical Solution-\nEach ml to contain: Heparin Sodium IP 1000 IU, Absolute Alcohol IP 10% v/v | Item no.: 2183 | 1 | 5ml |
123 | 123 | Tenofovir Alafenamide Tab/Cap-\nEach Tab/Cap to contains: Tenofovir Alafenamide 25mg | Item no.: 2184 | 1 | 1 Tab/Cap |
124 | 124 | Meningococcal Vaccine-\nEach Vial to contain: Meningococcal Group (A,C,Y And W135) Polysachharide Diphtheria Toxoid Conjugate Vaccine | Item no.: 2185 | 1 | 0.5 ml Vial |
125 | 125 | Snake Anti Venin (Polyvalent) IP 10ml (Enzyme Refined Equine Globulins)-\nEach 1ml Neutralises: 0.60mg Of Cobra Venom (Naja Naja), 0.45mg Of Common Krait Venom(Bungarus Caeruleus), 0.60mg Of Ruseells Viper Venom (Vipera Russelli), 0.45mg Of Saw Scaled Viper Venom (Echis Carinatus) | Item no.: 2186 | 1 | 10ml |
126 | 126 | Lenvatinib Tab/Cap- \nEach Tab/Cap to contains: Lenvatinib 4mg | Item no.: 2215 | 1 | 1 Tab/Cap |
127 | 127 | Lenvatinib Tab/Cap- \nEach Tab/Cap to contains: Lenvatinib 10mg | Item no.: 2216 | 1 | 1 Tab/Cap |
128 | 128 | Rabbit Antithymocyte Globulin -\nEach 5ml to contain: Rabbit Antithymocyte Globulin 25mg | Item no.: 2217 | 1 | 1 Vial/Amp |
129 | 129 | Daratumumab Inj-\nEach 5ml to contain: Daratumumab Concentrate For Solution For Infusion 100mg | Item no.: 2218 | 1 | 1 Vial |
130 | 130 | Daratumumab Inj-\nEach 20ml to contain: Daratumumab Concentrate For Solution For Infusion 400mg | Item no.: 2219 | 1 | 1 Vial |
131 | 131 | Pembrolizumab Inj-\nEach ml to contain: Pembrolizumab 25mg | Item no.: 2220 | 1 | 4ml Vial |
132 | 132 | Ribociclib Tab/Cap-\nEach Film Coated Tab/Cap Contains: Ribociclib 200mg | Item no.: 2221 | 1 | 1 Tab/Cap |
133 | 133 | Midostaurin Tab/Cap-\nEach Tab/Cap Contains:Midostaurin 25mg | Item no.: 2222 | 1 | 1 Tab/Cap |
134 | 134 | Mycophenolate Mofetil Powder-\nEach Bott to contain: Mycophenolate Mofetil Powder For Oral Suspension 1gm/5ml | Item no.: 2223 | 1 | 1 Bottle with 110gm powder for oral susp. Containing 35gm Mycophenolate Mofetil |
135 | 135 | Paclitaxel (Protein Bound Particales)-\nEach Inj to contain: Paclitaxel (Protein Bound Particales) For Injectable Suspension 100 Mg And This Is An Albumin-Bound Form Of Paclitaxel And This Is Presented As 100 Mg Of Paclitaxel In A Single Use 50 ml USP Type 1 Molded Glass Vial Individually Packaged In a Carton | Item no.: 2225 | 1 | 1 inj |
136 | 136 | Human Immunoglobulin-\nEach Bott to contain: Human Immunoglobulin 50g/Lit, Maltose 100g/Lit , Water for injection Q.S | Item no.: 2226 | 1 | 100ml bott |
137 | 137 | Human Papillomavirus-\nEach 0.5ml to contain: Human Papillomavirus Quadrivalent (6, 11, 16 , 18 ) Vaccine, Recombinant | Item no.: 2227 | 1 | 0.5ml |
138 | 138 | Mepolizumab Inj- \nEach Vial to contain: Mepolizumab 100mg | Item no.: 2319 | 1 | 1 Vial |
139 | 139 | Cytarabine Inj-\nEach ml to contain: Cytarabine1 gm | Item no.: 2320 | 1 | 1Vial/Amp |
140 | 140 | Daunorubicin Inj- \nEach Vial/Amp to contain: Daunorubicin-20 Mg | Item no.: 2321 | 1 | 1Vial/Amp |
141 | 141 | Mitomycin Inj- \nEach Vial/Amp to contain: Mitomycin 2mg | Item no.: 2322 | 1 | 1Vial/Amp |
142 | 142 | Docetaxel Inj- \nEach Vial/Amp to contain: Docetaxel 20mg | Item no.: 2323 | 1 | 1Vial/Amp |
143 | 143 | Docetaxel Inj- \nEach Vial/Amp to contain: Docetaxel 120mg | Item no.: 2324 | 1 | 1Vial/Amp |
144 | 144 | Mesna Inj- \nEach Vial/Amp to contain: Mesna 200mg | Item no.: 2325 | 1 | 1Vial/Amp |
145 | 145 | Vinblastine Sulphate Inj- \nEach Vial/Amp to contain: Vinblastine Sulphate 10mg | Item no.: 2326 | 1 | 1Vial/Amp |
146 | 146 | Alfa Ketoanalogue Tab/Cap- \nEach Tab/Cap to contain: Alpha Ketoanalogue 381mg, L-Histidine 38m, L-Lysine 105mg,L-Threonine 53mg, Tryptophan 23mg, Tyrosine 30mg | Item no.: 2327 | 1 | 1 Tab/Cap |
147 | 147 | Calcium Polystyrene Sulfonate Sachet- \nEach Sachet to contain: Calcium Polystyrene Sulfonate 15 gm | Item no.: 2328 | 1 | 1 Sachet |
148 | 148 | Denosumab Inj- \nEach PFS to contain: Denosumab 60mg | Item no.: 2329 | 1 | 1 PFS |
149 | 149 | Ibandronic Acid Tab/Cap- \nEach Tab/Cap to contain: Ibandronic Acid- 150mg | Item no.: 2330 | 1 | 1 Tab/Cap |
150 | 150 | Octreotide Inj- \nEach Vial/Amp to contain: Octreotide 100mcg | Item no.: 2331 | 1 | 1Vial/Amp |
151 | 151 | Somatostatin Acetate Inj- \nEach Vial/Amp to contain:Somatostatin Acetate 250mcg | Item no.: 2332 | 1 | 1Vial/Amp |
152 | 152 | Cinacalcet Tab/Cap- \nEach Tab/Cap to contain: Cinacalcet 30mg | Item no.: 2333 | 1 | 1 Tab/Cap |
153 | 153 | Anti Rabies Serum Equine Inj- \nEach ml to contain: Equine Antirabies Immunoglobulin 300 IU | Item no.: 2334 | 1 | 5ml Vial |
154 | 154 | Tetanus Toxoid (Adsorbed) Inj- \nEach Dose Of 0.5ml to contain : Tetanus Toxoid 5/LFS | Item no.: 2335 | 1 | 5ml Vial |
155 | 155 | Pneumococcal Vaccine- \nEach 0.5ml to contain: Pneumococcal Polysaccharide Conjugate Vaccine (13 Valent) | Item no.: 2336 | 1 | 1 PFS |
156 | 156 | Pralidoxime Inj- \nEach Vial/Amp to contain : Pralidoxime 500 mg | Item no.: 2337 | 1 | 1 Vial/Amp |
157 | 157 | Tuberculin PPD Inj-\nEach Vial/Amp to contain -Tuberculin Purified Protien Derivative 5TU/0.1ml | Item no.: 2338 | 1 | 5ml Vial/Amp |
158 | 158 | CAPD Catheter- \nDouble Cuff - Curl Cath - 57 Cm Approx (Adult) | Item no.: 2339 | 1 | 1 Cuff |
159 | 159 | CAPD Catheter- \nDouble Cuff - Curl Cath - 42 Cm (Paediatric) | Item no.: 2340 | 1 | 1 Cuff |
160 | 160 | Outlet Port Clamp | Item no.: 2341 | 1 | 1 Clamp |
161 | 161 | Favipiravir Tab/Cap- \nEach Tab/Cap to contain: Favipiravir 200mg | Item no.: 2342 | 1 | 1 Tab/Cap |
162 | 162 | Remdesivir Inj- \nEach Vial/Amp to contain: Remdesivir 100mg | Item no.: 2343 | 1 | 1 Vial/Amp |
163 | 163 | Cisplatin Inj- \nEach Vial to contain: Cisplatin IP 10mg | Item no.: 1329a | 1 | 1 Vial |
164 | 164 | Cisplatin Inj- \nEach Vial to contain: Cisplatin IP 50mg | Item no.: 1329b | 1 | 1 Vial |
165 | 165 | Cyclophosphamide Inj- \nEach Vial to contain: Cyclophosphamide IP 200mg | Item no.: 1330b | 1 | 1 Vial |
166 | 166 | Mitomycin Inj- \nEach Vial to contain: Mitomycin 10mg | Item no.: 1331b | 1 | 1 Vial |
167 | 167 | Human Tetanus Specific Immunoglobulin- \nEach Vial to contain: Human Tetanus Specific Immunoglobulin 250 Units. | Item no.: 1339a | 1 | 1 Vial |
168 | 168 | Human Tetanus Specific Immunoglobulin- \nEach Vial to contain: Human Tetanus Specific Immunoglobulin 500 Units. | Item no.: 1339b | 1 | 1 Vial |
169 | 169 | Epirubicin Inj- \nEach Inj to contain: Epirubicin Hydrochloride 10mg | Item no.: 1407a | 1 | 1 Vial |
170 | 170 | Epirubicin Inj- \nEach Inj to contain: Epirubicin Hydrochloride 50mg | Item no.: 1407b | 1 | 1 Vial |
171 | 171 | Peritoneal Dialysis Fluids 1.5%- \nEach 100ml to contain: Dextrose Anhydrous 1.5gm, Sodium Lactate 448mg, Na Cl 538mg, Ca Cl 25.7mg, Mg Cl 5.08mg | Item no.: 1409a | 1 | 2Ltr Bag |
172 | 172 | Peritoneal Dialysis Fluids 2.5%- \nEach 100ml to contain: Dextrose Anhydrous 2.5gm, Sodium Lactate 448mg, Na Cl 538mg, Ca Cl 25.7mg, Mg Cl 5.08mg | Item no.: 1410a | 1 | 2Ltr Bag |
173 | 173 | Peritoneal Dialysis Fluids 4.25%- \nEach 100ml to contain: Dextrose Anhydrous 4.25gm, Sodium Lactate 448mg, Na Cl 538mg, Ca Cl 25.7mg, Mg Cl 5.08mg | Item no.: 1411a | 1 | 2Ltr Bag |
174 | 174 | Dasatinib Tab/Cap- \nEach TabCap to contain: Dasatinib 20mg | Item no.: 1447a | 1 | 1 Tab/Cap |
175 | 175 | Dasatinib Tab/Cap- \nEach Tab/Cap to contain: Dasatinib 50mg | Item no.: 1447b | 1 | 1 Tab/Cap |
176 | 176 | Dasatinib Tab/Cap- \nEach Tab/Cap to contain: Dasatinib 70mg | Item no.: 1447c | 1 | 1 Tab/Cap |
177 | 177 | Capecitabine Tab/Cap- \nEach Tab/Cap to contain: Capecitabine 500mg | Item no.: 1454b | 1 | 1 Tab/Cap |
178 | 178 | Low Calcium CAPD- \nEach to contain: CAPD Bags With 1.5% Concentration Containing 40 mEq/Litre Of Lactate and 2.5 mEq/Litre Of Ca With Asymmetrical Y Connector | Item no.: 1455a | 1 | 2Ltr Bag |
179 | 179 | Low Calcium CAPD- \nEach to contain: CAPD Bags With 2.5% Concentration Containing 40 mEq/Litre Of Lactate and 2.5 mEq/Litre Of Ca With Asymmetrical Y Connector | Item no.: 1455b | 1 | 2Ltr Bag |
180 | 180 | Sunitinib Malate Tab/Cap- \nEach Tab/Cap to contain: Sunitinib Malate 12.5mg | Item no.: 1473a | 1 | 1 Tab/Cap |
181 | 181 | Sunitinib Malate Tab/Cap- \nEach Tab/Cap to contain: Sunitinib Malate 25mg | Item no.: 1473b | 1 | 1 Tab/Cap |
182 | 182 | Everolimus Tab/Cap- \nEach Tab/Cap to contain: Everolimus 0.75mg | Item no.: 1474c | 1 | 1 Tab/Cap |
183 | 183 | Deferasirox Tab/Cap- \nEach Tab/Cap to contain Deferasirox 100mg | Item no.: 1476a | 1 | 1 Tab/Cap |
184 | 184 | Deferasirox Tab/Cap- \nEach Tab/Cap to contain Deferasirox 400mg | Item no.: 1476b | 1 | 1 Tab/Cap |
185 | 185 | Filgrastim Inj- \nEach PFS/Vial to contain: Filgrastim 150 mcg | Item no.: 1650a | 1 | 1 PFS/ Vial |
186 | 186 | Hepatitis B Immunoglobulin Inj- \nEach 0.5ml to contain:Hepatitis B Immunoglobulin 100 IU | Item no.: 1652a | 1 | 0.5ml Vial |
187 | 187 | Hepatitis B Immunoglobulin Inj- \nEach 1ml to contain: Hepatitis B Immunoglobulin 200 IU | Item no.: 1652b | 1 | 1ml Vial |
188 | 188 | Hepatitis B Vaccine( r-DNA)- \nEach Vial to contain: 20mcg Of Hepatitis B Surface Antigen. | Item no.: 284a | 1 | 1 Vial |
189 | 189 | Hepatitis B Vaccine( R-DNA)- \nEach Vial to contain: 10 mcg Of Hepatitis B Surface Antigen. | Item no.: 284b | 1 | 1 Vial |
190 | 190 | Hepatitis B Vaccine (R-DNA)- \nEach ml to contain: 20mcg Of Hepatitis B Surface Antigen | Item no.: 284c | 1 | 10ml Vial |
191 | 191 | Gemcitabine Inj- \nEach Vial to contain: Gemcitabine 200mg | Item no.: 459a | 1 | 1 Vial |
192 | 192 | Gemcitabine Inj- \nEach Vial to contain: Gemcitabine 1gm | Item no.: 459b | 1 | 1 Vial |
193 | 193 | Paclitaxel Inj- \nEach Vial to contain: Paclitaxel 100mg | Item no.: 487a | 1 | 1 Vial |
194 | 194 | Paclitaxel Inj- \nEach Vial to contain: Paclitaxel IP 200mg | Item no.: 487b | 1 | 1 Vial |
195 | 195 | Carboplatin Inj- \nEach Vial to contain: Carboplatin 150mg | Item no.: 488a | 1 | 1 Vial |
196 | 196 | Carboplatin Inj- \nEach Vial to contain: Carboplatin 450mg | Item no.: 488b | 1 | 1 Vial |
197 | 197 | Alendronate Tab/Cap- \nEach Tab/Cap to contain: Alendronate 35mg | Item no.: 578a | 1 | 4 Tab/Cap |
198 | 198 | Alendronate Tab/Cap- \nEach Tab/Cap to contain: Alendronate 70mg | Item no.: 578b | 1 | 1 Tab/Cap |
Copyright © 2024 · All Rights Reserved. Terms of Usage | Privacy Policy
For Tender Information Services Visit : TenderDetail